Grey Matters Health Inc.

Grey Matters Health Inc.

AGNPF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$973.34K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Grey Matters Health Inc.Grey Matters Health Inc.0--140%-0.4
$0.04

Current Fair Value

76.7% downside

Overvalued by 76.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$973,335.00
Enterprise Value$1.71 Million
Earnings per Share$-0.58
Beta0.29
Outstanding Shares5,422,477

Return

Return on Equity-140.39%ROE
Return on Assets-46.63%
Return on Invested Capital-63.57%

Valuation & Multiples

P/E Ratio-P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-1.09
Enterprise Value to Net Income-1
Total Debt to Enterprise0.46
Debt to Equity0.44Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
July 29, 2026
EPS
-$0.09
Est. -$4.97
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
December 18, 2026
EPS Estimate
-$3.34
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Grey Matters Health Inc.

5 employees
CEO: Christopher J. Moreau

Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulation...